4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)-N-methyl-N-(pyridin-4-yl)benzamide
CAS No.：
Cat. No.: SC261809
Available on Request
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :4-(3-(4-cyanophenyl)imidazo[1,2-a]pyridin-6-yl)-N-methyl-N-(pyridin-4-yl)benzamide
Cat. No.: :SC261809
Purity / Specification :—
CAS No. :1618681-79-0
MDL No. :—
Molecular Formula :C22H16N4O
LogP :4.15
Molecular Weight :352.40
TPSA :61.4
Category :Drug Discovery
HSN Code :—
SMILES Code :CN(C(=O)c1ccc2ncc(-c3ccc(C#N)cc3)n2c1)c1ccccc1
Melting Point :—
InChI Key : :SZTIJPADKKCCKK-UHFFFAOYSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✓ 352.4 Da
LogP ≤ 5✓ 4.15
HBD ≤ 5✓ 0
HBA ≤ 10✓ 3
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i83/100
Good drug-like profile
Predicted LogP
i4.15log units
Lipophilic
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS± borderline
TPSA 61.4Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.